Hi koo.

Just curious. How do you know Don is out of the equation. He certainly should be after the AGM update.

I used to believe that the science would win on it's own. But we have years to wait for an NDA if we are lucky and even then incompetent management can easily result in an undervaluation.

Biotech is a highly competitive game of competition for $ among great scientific ideas. The scientific team at RVX is well educated, successful and well paid with the exception or Dr Kulikowski whose salry seems to low relative to her contributions. The business team at RVX has neither the business educations nor breadth of biotech experience to survive in this jungle. Their lack of hustle and urgency is clear evidence. The small and insider based BOD has demonstrated their incompetence.

I sure hope narmac is correct but RVX is a club or a fraternity that protects it's members and only the great science escapes their tight rules most often the result of independent biotech professors doing their own research on apabetalone.

Keep in mind that during this biotech downturn Don's monthly salary has risen from what I recall was about $27,500/month a couple of years ago to about $42,100/month. and now RVX is on summer vacation. So Don will collect $84,200 in salary  while on the links or at his beach in Hawaii and this is in spite of 2 years of failure. Hats off to the independent RVX Compensation Committee. Great job folks!

Cheers

Toinv